Catheter-delivered in vivo gene transfer into rat myocardium using the fusigenic liposomal mediated method

Japanese Heart Journal

Volumn 41, Issue 5, 2000, Pages 633-647

  Shinmura, Ken ^a   Morishita, Ryuichi ^a   Aoki, Motokuni ^a   Higaki, Jitsuo ^a   Ogihara, Toshio ^a   Kaneda, Yasufumi ^b   Tani, Masato ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Coronary circulation; Gene expression; Gene therapy; Histopathology; Myocytes

Indexed keywords

BETA GALACTOSIDASE; FLUORESCEIN ISOTHIOCYANATE; LIPOSOME; LUCIFERASE; OLIGODEOXYNUCLEOTIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA FLOW; ARTICLE; BALLOON CATHETER; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENE TRANSFER; HEART LEFT VENTRICLE; HEART MUSCLE; HEART MUSCLE CELL; HISTOPATHOLOGY; IN VIVO STUDY; INTERMETHOD COMPARISON; MALE; NONHUMAN; PARAINFLUENZA VIRUS 1; PRIORITY JOURNAL; RAT; SAFETY;

EID: 0033636281     PISSN: 00214868     EISSN: None     Source Type: Journal    
DOI: 10.1536/jhj.41.633     Document Type: Article

References (35)

1. Human gene therapy
2. Human gene therapy comes of age
3. Efficient gene transfer into myocardium by direct injection of adenovirus vectors
4. Highly efficient gene transfer into adult ventricular myocytes by recombinant adenovirus
5. The advent of adenovirus gene therapy for cardiovascular disease
6. Efficient catheter-mediated gene transfer into the heart using replication-defective adenovirus
7. Direct in vivo gene transfer into porcine myocardium using replication-deficient adenoviral vectors
8. Gene therapy in the cardiovascular diseases
9. Gene therapy as potential treatment for cardiovascular diseases
10. Efficient in vivo gene transfer into the heart in the rat myocardial infarction model using the HVJ (Hemagglutinating Virus of Japan) - Liposome method
11. Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia
12. Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides
13. CDC, Pharmacokinetics of antisense oligodeoxyribonucleotides (cyclin B1, 2 kinase) in the vessel wall in vivo: Enhanced therapeutic utility for restenosis by HVJ-liposome delivery
14. A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo
15. Introduction and expression of the human insulin gene in adult rat liver
16. Gene therapy inhibiting neointimal vascular lesion: In vivo transfer of endothelial cell nitric oxide synthase gene
17. Antisense of oligonucleotides directed at cell cycle regulatory genes as strategy for restenosis therapy
18. Direct in vivo gene introduction into rat kidney
19. Evidence for direct local effect of angiotensin in vascular hypertrophy In vivo gene transfer of angiotensin converting enzyme
20. Direct injection of hepatitis B virus DNA into liver induced hepatitis in adult rats
21. Increased expression of DNA cointroduced with nuclear protein in adult rat liver
22. Efficient introduction of contents of liposomes into cells using HVJ (Sendai virus)
23. Fusigenic viral liposome for gene therapy in cardiovascular diseases
24. Direct gene transfer and expression into rat heart in vivo
25. Behavior of genes directly injected into the rat heart in vivo
26. Direct myocardial transfection in two animal models. Evaluation of parameters affecting gene expression and percutaneous gene delivery
27. Hormonal modulation of a gene injected into rat heart in vivo
28. Expression of recombinant genes in myocardium in vivo after direct injection of DNA
29. Gene injection into canine myocardium as a useful model for studying gene expression in the heart of large mammals
30. In vivo gene transfection of human endothelial cell nitric oxide synthase in cardiomyocytes causes apoptosis-like cell death. Identification using Sendai virus-coated liposomes
31. Precise identification of gene products in hearts after in vivo gene transfection, using Sendai virus-coated proteoliposomes
32. Percutaneous transluminal in vivo gene transfer by recombinant adenovirus in normal porcine coronary arteries, atherosclerotic arteries, and two models of coronary restenosis
33. In vivo gene transfer and expression in normal uninjured blood vessels using replication-deficient recombinant adenovirus vectors
34. Fusigenic liposome-mediated DNA transfer into cardiac myocytes
35. Efficiency of in vivo gene transfection into transplanted rat heart by coronary infusion of HVJ liposome